FLASHKNiFE is a radiotherapy device developed by THERYQ, designed to deliver electron FLASH radiotherapy at ultra-high dose rates of up to 300 Gy/s in a fraction of a second. Intended for the future treatment of superficial lesions eligible for external radiotherapy, FLASHKNiFE aims to translate the FLASH approach from preclinical research into clinical applications. The device integrates a 6 and 9 MeV linac with an interactive 6-axis robot arm on a mobile base, ensuring precise applicator positioning close to the tumor. This flexibility enables both external beam and intraoperative radiotherapy applications.
Learn more at THERYQ and visit us at booth 639 at ASTRO 2025.
Note: FLASHKNiFE is not clinically available.
Want more information about this product?
Fill out a small form and let the company know you are interested in their product. It's free and easy.